Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
2014-April Volume 7 Issue 4

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
2014-April Volume 7 Issue 4

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Clinical characteristics of nonglaucomatous optic disc cupping

  • Authors:
    • Yi-Xin Zhang
    • Hou-Bin Huang
    • Shi-Hui Wei
  • View Affiliations / Copyright

    Affiliations: Department of Ophthalmology, Hainan Branch of General Hospital of PLA, Sanya, Hainan 572013, P.R. China, Department of Ophthalmology, General Hospital of PLA, Beijing 100853, P.R. China
  • Pages: 995-999
    |
    Published online on: January 28, 2014
       https://doi.org/10.3892/etm.2014.1508
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Pathological optic disc cupping (ODC) is predominantly referred to as glaucoma; however, it is not only glaucoma that leads to pathological optic disc excavation. A number of other nonglaucomatous diseases also result in optic atrophy and excavation of the optic disc. Therefore, in the present study, the etiology of nonglaucomatous optic disc cupping (NGODC) was analyzed and differentiated from glaucomatous optic disc cupping (GODC). The morphology and clinical data of 19 eyes, from 12 patients exhibiting NGODC, were analyzed. Of the 12 cases, none were diagnosed with glaucoma, four presented with optic neuritis, one with Devic's disease, one with Leber's hereditary optic neuropathy, two with pituitary adenoma, one with basal ganglia cerebral hemorrhage, one with cilioretinal artery occlusion associated with central retinal vein occlusion, one with central retinal artery occlusion and the remaining patient exhibited optic nerve injuries. The key features that differentiated NGODC from GODC were the color of the optic disc rim and the correlation between visual field defects and the disc appearance. The focally notched disc also aided in distinguishing between the two disorders. The results of the present study indicated that it is critical to acknowledge that nonglaucomatous diseases also lead to ODC and that distinguishing between them is necessary.

Introduction

Pathological optic disc cupping (ODC) is frequently associated with glaucoma and other less common neuro-ophthalmic conditions (1). Optic atrophy, as a result of numerous nonglaucomatous diseases, may also lead to ODC; however, this has received less consideration. Previous studies have indicated that ~20% of patients were misdiagnosed with glaucoma (2,3). Nonglaucomatous optic disc cupping (NGODC) is predominantly attributed to various optic nerve diseases (4,5); however, may also be a result of retinal diseases (6). Therefore, in the present study, patients with NGODC were analyzed based on data obtained from clinical information and examinations and certain patients were diagnosed with retinal disorders. Distinguishing characteristics between glaucomatous optic disc cupping (GODC) and NGODC are discussed in the present study.

Patients and methods

Patients

Medical records of patients who had been diagnosed with NGODC at the Chinese General Hospital of PLA (Beijing, China) between February 2008 and March 2013 were retrospectively reviewed. Informed consent was obtained from all the patients. In total, 19 eyes from 12 subjects (male, 6; female, 6) were analyzed in this study. The patient ages ranged between 8 and 63 (mean age, 39 years; Table I). The medical records of the patients were reviewed and a detailed history of current and past ophthalmic and systemic illnesses was constructed, including visual symptoms on presentation and their duration, medical, family and social histories and any medication previously prescribed.

Table I

Clinical data of 12 patients with NGODC.

Table I

Clinical data of 12 patients with NGODC.

Case no.GenderAge (years)DiagnosisEyeDuration of diseaseaMorphology of cuppingBCVAbVisual field defect
1F41Neuromyelitis opticaOS2 yearsDiffuseOD 0.2, OS
FC/20 cm
Central scotoma
2M18LHONOU2 yearsDiffuseOD 0.1, OS 0.05Central scotoma
3F62CLRAO, CRVOOD10 monthsDiffuseOD 0.15, OS 0.25Inferior defect
4M26Pituitary adenomaOU10 monthsBilateral nasal (more serious OD)OD 0.8, OS 0.8Bitemporal hemianopsia
5F31Cerebral hemorrhageOU13 monthsTemporal OS, nasal ODOD 1.0, OS 1.0Bilateral homonymous hemianopia in the right side
6M55Optic neuritisOD1 yearDiffuseOD 0.3Diffuse defect
7M47Optic neuritisOU10 monthsDiffuseOD 1.0, OS 0.12Diffuse defect OS, more serious superiorly. Superior defect OD
8F8Optic neuritisOU6 monthsDiffuseOD 0.8, OS 0.8Diffuse defect, more serious peripherally
9F48Optic neuritisOS1 yearDiffuse0.1Unknown
10M39Pituitary adenomaOU2 yearsDiffuseOD 1.2, OS
HM before eye
Diffuse defect OS
Nasal hemianopia OD
11F30Optic nerve injuryOU2 yearsDiffuseNLP, OUUnavailable
12M63CRAOOD3 monthsDiffuse0.1Diffuse defect

a Indicates the time period between the clinical discovery of ODC and onset of the disease.

b Indicates BCVA post follow-up.

{ label (or @symbol) needed for fn[@id='tfn3-etm-07-04-0995'] } NGODC, nonglaucomatous optic disc cupping; F, female; M, male; LHON, Leber’s hereditary optic neuropathy; CLRAO, cilioretinal artery occlusion; CRVO, central retinal vein occlusion; CRAO, central retinal artery occlusion; OS, oculus sinister; OU, oculus uterque; OD, oculus dexter; FC, finger counting; HM, hand movement; NLP, no light perception; BCVA, best corrected visual acuity.

Ophthalmic evaluation

Patients underwent a detailed ophthalmic evaluation with particular focus on visual acuity, visual fields, relative afferent pupillary defects, slit-lamp (Topcon Inc., Tokyo, Japan) examinations of the anterior segment, lens and vitreous, intraocular pressure (IOP) (Canon Non-Contact Tonometer; Canon Inc., Tokyo, Japan), ocular movements and fundus evaluation by indirect and direct ophthalmoscopy (also by contact lens if required), as well as additional clinical parameters. Color fundus images (Canon CX-1 fundus camera; Canon Inc., Tokyo, Japan), fluorescein fundus angiography (Heidelberg Retina Tomograph HRT-3; Heidelberg Engineering, Inc., Heidelberg, Germany), optical coherence tomography (Zeiss Cirrus 4000 OCT, Carl Zeiss Meditec, Inc., Dublin, CA, USA), perimetry (Humphrey 740i Field Analyzer, Carl Zeiss Meditec, Inc.) and visual electrophysiology (Roland Electrophysiological diagnostic systems; Roland Consult, Stasche & Finger GmbH, Brandenburg an der Havel, Germany) were also performed.

Statistical analysis

SPSS 19.0 software (SPSS, Inc., Chicago, IL, USA) was used for statistical analysis. The correlation between IOP and the cup/disc (C/D) ratio was analyzed and compared with analysis of variance. In addition, the data were analyzed using a curve fitting model.

Results

Analysis of morphology and clinical data

Of the 12 cases, none were diagnosed with glaucoma, four exhibited optic neuritis, one had Devic’s disease, one had Leber’s hereditary optic neuropathy (LHON), two had a pituitary adenoma, one had a basal ganglia cerebral hemorrhage, one exhibited cilioretinal artery occlusion (CLRAO) associated with central retinal vein occlusion (CRVO), one exhibited central retinal artery occlusion (CRAO) and the remaining patient exhibited optic nerve injuries. The clinical data are described in Table I and selected cases are detailed as follows (the case number refers to the patient number in Table I).

The mean IOP of the affected eyes of the 12 subjects was 14.5±3.8 mmHg (n=19), as compared with the healthy eyes that had a mean IOP of 14.4±1.3 mmHg (n=5). There was no statistically significant difference (F=4.30; P=0.892). The mean C/D ratio in the affected eyes was 0.83±0.10 and 0.38±0.01 in the healthy eyes (F=4.30; P<0.01). There was no correlation between IOP and the C/D ratio (correlation coefficient, 0.184; P>0.05).

Representative cases
Case 2

An 18-year-old male complained of a sequential decrease in binocular vision over two years. IOPs were 16 mmHg oculus dexter (OD) and 14 mmHg oculus sinister (OS). The patient was diagnosed with LHON that had been caused by a 11778A mtDNA mutation. Bilateral optic disc appearance was characterized via diffuse excavation of the optic cup and rim pallor (Fig. 1). A central scotoma was the predominant visual field defect observed.

Figure 1

Fundus images of a LHON patient. (A) Right and (B) left retinas exhibit ODC, diffuse rim loss and rim pallor. LHON, Leber’s hereditary optic neuropathy; ODC, optic disc cupping.

Case 3

A 62-year-old female with CLRAO and CRVO of the right eye exhibited increasing excavation of the cup with superior and inferior rim loss. Temporal rim pallor was identified in the follow-up examinations (Fig. 2). IOP was 15 mmHg OD.

Figure 2

Fundus images of a patient exhibiting CLRAO and CRVO. (A) Retinal manifestation observed at the initial visit, exhibiting retinal vein dilation, retinal hemorrhage and retinal infarct corresponding to the region of CLRAO. (B) Fundus image one month after the initial visit. (C) Fundus manifestation ten months after the initial visit. Gradual diffuse excavation of the optic disc between A and C is apparent. CLRAO, cilioretinal artery occlusion; CRVO, central retinal vein occlusion.

Case 5

A 31-year-old female complained of a visual field defect of the right eye over a six-month period. IOPs were 14 mmHg OD and 14 mmHg OS. A magnetic resonance imaging scan revealed a hemorrhage in the left basal ganglia, which also involved the left cerebral peduncle and basal ganglia. Left temporal and right nasal disc pallor and rim loss were observed with the corresponding visual field defect of right homonymous hemianopia (Fig. 3).

Figure 3

Fundus images of a patient exhibiting a hemorrhage in the left basal ganglia obtained 13 months after the onset of bleeding. (A) Nasal rim loss was apparent in the right eye, predominantly in the superior nasal region. (B) Rim loss in the left eye was located in the temporal region.

Case 7

A 47-year-old male experienced decreased vision in both eyes for ten months. The patient had been diabetic for three years. IOPs were 17 mmHg OD and 16 mmHg OS. Optic disc excavation and disc pallor were identified in both eyes, but was more serious in the left eye (Fig. 4). The patient exhibited congenital physiological ODC with disc pallor as a result of optic atrophy following optic neuritis.

Figure 4

Fundus images of a patient exhibiting optic neuritis. (A) Right and (B) left retinas show ODC, however, optic disc pallor was apparent in the left eye. The patient was diagnosed with physiological ODC and left optic atrophy. ODC, optic disc cupping.

Discussion

A strong association was observed between neuro-ophthalmic diseases and pathological ODC in the present study. In addition to glaucoma, other retinal diseases contribute to NGODC (6). Retinal and optic nerve head diseases are often associated with NGODC, including arteritic anterior ischemic optic neuropathy (AION; 7–10), which is the most common cause despite being rarely observed in China. In the present study, one patient with CLRAO and CRVO also exhibited NGODC, which to the best of our knowledge, is the first such case to be reported in literature. Furthermore, optic neuropathies may lead to NGODC, including LHON, autosomal dominant hereditary optic atrophy, optic neuritis, toxic optic neuropathy (e.g. methanol poisoning) and traumatic neuropathy. In addition, chiasmatic diseases and other diseases, including anterior segmental optic nerve compression, cerebrovascular diseases, radiation optic neuropathy and carotid artery stenosis, occasionally lead to NGODC (6). Previous studies have focused on other causes, such as retrograde transsynaptic degeneration of retinogeniculate axons following periventricular leukomalacia (11), physiological cupping and nonglaucomatous optic atrophy, which are additional manifestations of NGODC.

A normal optic disc usually forms a vertical oval shape with a vertical diameter that is 7–10% greater than the horizontal diameter. The optic cup is horizontally oval, thus, the horizontal C/D ratio is larger than the vertical C/D ratio. In healthy individuals, the median C/D ratio value is <0.3 and the difference in the C/D ratios between the fellow eye is <0.2. Therefore, a ratio greater than 0.6 is indicative of ODC. The color of a normal rim is orange due to the presence of capillaries. In the majority of cases, a normal width follows the inferior, superior, nasal, temporal (ISNT) rule, thus, the neuroretinal rim is broadest in the inferior disc region, followed by the superior disc region, the nasal disc area and finally the temporal disc portion. However, violation of the ISNT rule also occurs in large optic disc cups of nonglaucomatous origin, with a greater frequency in the pediatric population (12).

Changes in the optic disc as a result of glaucoma include focal or concentric enlargement, where the vertical diameter change is disproportionate to the horizontal change. Additional traits include deepened excavation, increased exposure of the lamina cribrosa, diffuse rim loss, wedge-shaped nerve fiber layer defects, flame-shaped disc hemorrhages and beta zones of parapapillary atrophy in accordance with nerve fiber layer defects (13).

Several key differences were observed between NGODC and GODC (14–16). Firstly, the color of the rim is the most important. The rim of NGODC often exhibits pallor, while the rim in GODC is pink. However, differentiating between NGODC and GODC according to rim color is very difficult in end-stage glaucoma when the C/D ratio is ~1.0. Secondly, the presence of focal or diffuse rim loss is important. Focal rim loss is predominantly associated with glaucoma, while eyes with nonglaucomatous diseases are often characterized by diffuse rim loss. Although focal rim loss may occasionally be present in NGODC, total loss of the disc rim is never observed. Thirdly, there is a high correlation between visual field defects and disc changes in GODC, but a marginal correlation between these parameters in NGODC (4,14,15). Fourthly, IOP may or may not be within the normal range. Fifthly, ODC is apparent prior to visual field defects in GODC. Visual acuity decreases markedly in NGODC with apparent visual field losses, but with marginal associated changes in the optic cup. Finally, peripapillary atrophy is an increasingly common observation in GODC as compared with NGODC.

Physiological cupping is a congenital disorder of optic cupping, which is caused by the scleral optic canal and pronounced glial atrophy of Bergmeister’s papilla. GODC is a type of ascending optic nerve atrophy that is associated with the loss of retinal ganglion cell axons. These changes extend anterogradely (upwards) along the pathological axons, which is followed by neuroretinal rim loss and increased exposure of the lamina cribrosa. In eyes exhibiting glaucomatous damage, rim loss is predominantly identified in the inferior and superior disc regions, thus, cupping is prone to vertical expansion. Focal or diffuse rim loss is associated with the distribution of nerve fibers and the impaired area. NGODC, resulting from optic nerve diseases, is an abnormality of retrograde (descending) optic atrophy, the mechanisms of which include prelaminar tissue atrophy, postlaminar tissue fibrosis, the shrinkage of fiber longitudinales, glial hyperplasia, bowing back of the lamina cribrosa following loss of support and damage to the laminar neurological and connective tissue caused by ischemia (7).

Eyes with non-arteritic AION (NA-AION) do not develop ODC. Patients with NA-AION usually exhibit a small or no optic cup, which may contribute to the pathology (7). However, the damage and atrophy of retinal ganglion cell axons in NA-AION is not as serious as that observed in arteritic AION, in which occlusion of the posterior ciliary arteries is a key event in pathogenesis and results in greater diffuse damage (7).

In conclusion, the key differentiating features between NGODC and GODC are the optic disc rim color and the correlation between visual field defects and the disc appearance. Focal rim loss also aids with distinguishing between the two diseases. However, methods of distinguishing NGODC from GODC should rely on patient history, visual field assessment and clinical data. Physicians and ophthalmologists are required to be vigilant to uncommon and potentially threatening forms of NGODC.

Acknowledgements

The study was supported by a grant from the 12th five-year National Sci-Tech Support Plan for the Clinical Research of Optic Neuritis, China (no. 2012BAI08B06).

Abbreviations:

ODC

optic disc cupping

GODC

glaucomatous optic disc cupping

NGODC

nonglaucomatous optic disc cupping

IOP

intraocular pressure

C/D

cup/disc ratio

LHON

Leber’s hereditary optic neuropathy

CLRAO

cilioretinal artery occlusion

CRVO

central retinal vein occlusion

CRAO

central retinal artery occlusion

OD

oculo dextro

OS

oculus sinister

AION

anterior ischemic optic neuropathy

ISNT

inferior, superior, nasal, temporal

NA-AION

non-arteritic anterior ischemic optic neuropathy

References

1 

Ambati BK and Rizzo JF III: Nonglaucomatous cupping of the optic disc. Int Ophthalmol Clin. 41:139–149. 2001. View Article : Google Scholar : PubMed/NCBI

2 

Piette SD and Sergott RC: Pathological optic-disc cupping. Curr Opin Ophthalmol. 17:1–6. 2006. View Article : Google Scholar : PubMed/NCBI

3 

Trobe JD, Glaser JS, Cassady J, Herschler J and Anderson DR: Nonglaucomatous excavation of the optic disc. Arch Ophthalmol. 98:1046–1050. 1980. View Article : Google Scholar : PubMed/NCBI

4 

Golnik K: Nonglaucomatous optic atrophy. Neurol Clin. 28:631–640. 2010. View Article : Google Scholar

5 

Bianchi-Marzoli S, Rizzo JF III, Brancato R and Lessell S: Quantitative analysis of optic disc cupping in compressive optic neuropathy. Ophthalmology. 102:436–440. 1995. View Article : Google Scholar : PubMed/NCBI

6 

Roodhooft JM: Nonglaucomatous optic disk atrophy and excavation in the elderly. Bull Soc Belge Ophtalmol. 287:45–49. 2003.PubMed/NCBI

7 

Hayreh SS and Jonas JB: Optic disc morphology after arteritic anterior ischemic optic neuropathy. Ophthalmology. 108:1586–1594. 2001. View Article : Google Scholar : PubMed/NCBI

8 

Girkin CA, De Leon-Ortega J and Graf CM: Optic disc morphology after AAION. Ophthalmology. 109:1198–1201. 2002. View Article : Google Scholar : PubMed/NCBI

9 

Danesh-Meyer HV, Savino PJ and Sergott RC: The prevalence of cupping in end-stage arteritic and nonarteritic anterior ischemic optic neuropathy. Ophthalmology. 108:593–598. 2001. View Article : Google Scholar : PubMed/NCBI

10 

McLeod D: Optic disc morphology after AAION. Ophthalmology. 109:1201–1204. 2002. View Article : Google Scholar : PubMed/NCBI

11 

Brodsky MC: Periventricular leukomalacia: an intracranial cause of pseudoglaucomatous cupping. Arch Ophthalmol. 119:626–627. 2001. View Article : Google Scholar : PubMed/NCBI

12 

Pogrebniak AE, Wehrung B, Pogrebniak KL, Shetty RK and Crawford P: Violation of the ISNT rule in nonglaucomatous pediatric optic disc cupping. Invest Ophthalmol Vis Sci. 51:890–895. 2010. View Article : Google Scholar : PubMed/NCBI

13 

Jonas JB and Budde WM: Diagnosis and pathogenesis of glaucomatous optic neuropathy: morphological aspects. Prog Retin Eye Res. 19:1–40. 2000. View Article : Google Scholar : PubMed/NCBI

14 

Lee AG: Differentiating glaucomatous from nonglaucomatous optic atrophy. Ophthalmology. 106:8551999. View Article : Google Scholar : PubMed/NCBI

15 

Greenfield DS: Glaucomatous versus nonglaucomatous optic disc cupping: clinical differentiation. Semin Ophthalmol. 14:95–108. 1999. View Article : Google Scholar : PubMed/NCBI

16 

Greenfield DS, Siatkowski RM, Glaser JS, Schatz NJ and Parrish RK II: The cupped disc. Who needs neuroimaging? Ophthalmology. 105:1866–1874. 1998. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Zhang Y, Huang H and Wei S: Clinical characteristics of nonglaucomatous optic disc cupping. Exp Ther Med 7: 995-999, 2014.
APA
Zhang, Y., Huang, H., & Wei, S. (2014). Clinical characteristics of nonglaucomatous optic disc cupping. Experimental and Therapeutic Medicine, 7, 995-999. https://doi.org/10.3892/etm.2014.1508
MLA
Zhang, Y., Huang, H., Wei, S."Clinical characteristics of nonglaucomatous optic disc cupping". Experimental and Therapeutic Medicine 7.4 (2014): 995-999.
Chicago
Zhang, Y., Huang, H., Wei, S."Clinical characteristics of nonglaucomatous optic disc cupping". Experimental and Therapeutic Medicine 7, no. 4 (2014): 995-999. https://doi.org/10.3892/etm.2014.1508
Copy and paste a formatted citation
x
Spandidos Publications style
Zhang Y, Huang H and Wei S: Clinical characteristics of nonglaucomatous optic disc cupping. Exp Ther Med 7: 995-999, 2014.
APA
Zhang, Y., Huang, H., & Wei, S. (2014). Clinical characteristics of nonglaucomatous optic disc cupping. Experimental and Therapeutic Medicine, 7, 995-999. https://doi.org/10.3892/etm.2014.1508
MLA
Zhang, Y., Huang, H., Wei, S."Clinical characteristics of nonglaucomatous optic disc cupping". Experimental and Therapeutic Medicine 7.4 (2014): 995-999.
Chicago
Zhang, Y., Huang, H., Wei, S."Clinical characteristics of nonglaucomatous optic disc cupping". Experimental and Therapeutic Medicine 7, no. 4 (2014): 995-999. https://doi.org/10.3892/etm.2014.1508
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team